Literature DB >> 21705679

Risk factor modification and projections of absolute breast cancer risk.

Elisabetta Petracci1, Adriano Decarli, Catherine Schairer, Ruth M Pfeiffer, David Pee, Giovanna Masala, Domenico Palli, Mitchell H Gail.   

Abstract

BACKGROUND: Although modifiable risk factors have been included in previous models that estimate or project breast cancer risk, there remains a need to estimate the effects of changes in modifiable risk factors on the absolute risk of breast cancer.
METHODS: Using data from a case-control study of women in Italy (2569 case patients and 2588 control subjects studied from June 1, 1991, to April 1, 1994) and incidence and mortality data from the Florence Registries, we developed a model to predict the absolute risk of breast cancer that included five non-modifiable risk factors (reproductive characteristics, education, occupational activity, family history, and biopsy history) and three modifiable risk factors (alcohol consumption, leisure physical activity, and body mass index). The model was validated using independent data, and the percent risk reduction was calculated in high-risk subgroups identified by use of the Lorenz curve.
RESULTS: The model was reasonably well calibrated (ratio of expected to observed cancers = 1.10, 95% confidence interval [CI] = 0.96 to 1.26), but the discriminatory accuracy was modest. The absolute risk reduction from exposure modifications was nearly proportional to the risk before modifying the risk factors and increased with age and risk projection time span. Mean 20-year reductions in absolute risk among women aged 65 years were 1.6% (95% CI = 0.9% to 2.3%) in the entire population, 3.2% (95% CI = 1.8% to 4.8%) among women with a positive family history of breast cancer, and 4.1% (95% CI = 2.5% to 6.8%) among women who accounted for the highest 10% of the total population risk, as determined from the Lorenz curve.
CONCLUSIONS: These data give perspective on the potential reductions in absolute breast cancer risk from preventative strategies based on lifestyle changes. Our methods are also useful for calculating sample sizes required for trials to test lifestyle interventions.

Entities:  

Mesh:

Year:  2011        PMID: 21705679      PMCID: PMC3131219          DOI: 10.1093/jnci/djr172

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  32 in total

Review 1.  Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors.

Authors:  F E Harrell; K L Lee; D B Mark
Journal:  Stat Med       Date:  1996-02-28       Impact factor: 2.373

2.  Statistical design considerations in the NHLI multiple risk factor intervention trial (MRFIT). The Multiple Risk Factor Intervention Trial Group.

Authors: 
Journal:  J Chronic Dis       Date:  1977-05

3.  Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history.

Authors:  D A Berry; G Parmigiani; J Sanchez; J Schildkraut; E Winer
Journal:  J Natl Cancer Inst       Date:  1997-02-05       Impact factor: 13.506

4.  Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention.

Authors:  B Rockhill; D Spiegelman; C Byrne; D J Hunter; G A Colditz
Journal:  J Natl Cancer Inst       Date:  2001-03-07       Impact factor: 13.506

5.  Gail model for prediction of absolute risk of invasive breast cancer: independent evaluation in the Florence-European Prospective Investigation Into Cancer and Nutrition cohort.

Authors:  Adriano Decarli; Stefano Calza; Giovanna Masala; Claudia Specchia; Domenico Palli; Mitchell H Gail
Journal:  J Natl Cancer Inst       Date:  2006-12-06       Impact factor: 13.506

6.  Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group.

Authors: 
Journal:  Control Clin Trials       Date:  1998-02

Review 7.  Prevention of breast cancer in postmenopausal women: approaches to estimating and reducing risk.

Authors:  Steven R Cummings; Jeffrey A Tice; Scott Bauer; Warren S Browner; Jack Cuzick; Elad Ziv; Victor Vogel; John Shepherd; Celine Vachon; Rebecca Smith-Bindman; Karla Kerlikowske
Journal:  J Natl Cancer Inst       Date:  2009-03-10       Impact factor: 13.506

8.  Using clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive model.

Authors:  Jeffrey A Tice; Steven R Cummings; Rebecca Smith-Bindman; Laura Ichikawa; William E Barlow; Karla Kerlikowske
Journal:  Ann Intern Med       Date:  2008-03-04       Impact factor: 25.391

9.  Contribution of three components to individual cancer risk predicting breast cancer risk in Italy.

Authors:  P Boyle; M Mezzetti; C La Vecchia; S Franceschi; A Decarli; C Robertson
Journal:  Eur J Cancer Prev       Date:  2004-06       Impact factor: 2.497

10.  EPIC-Italy cohorts and multipurpose national surveys. A comparison of some socio-demographic and life-style characteristics.

Authors:  Stefano Calza; Claudia Specchia; Graziella Frasca; Rosario Tumino; Carlotta Sacerdote; Laura Fiorini; Rocco Galasso; Anna Vittoria Ciardullo; Domenico Palli; Simonetta Salvini; Vittorio Krogh; Sabina Sieri; Adriano Decarli
Journal:  Tumori       Date:  2003 Nov-Dec
View more
  38 in total

1.  Twenty-five years of breast cancer risk models and their applications.

Authors:  Mitchell H Gail
Journal:  J Natl Cancer Inst       Date:  2015-02-26       Impact factor: 13.506

2.  WCRF/AICR recommendation adherence and breast cancer incidence among postmenopausal women with and without non-modifiable risk factors.

Authors:  Sarah J O Nomura; Maki Inoue-Choi; DeAnn Lazovich; Kim Robien
Journal:  Int J Cancer       Date:  2016-02-03       Impact factor: 7.396

3.  The burden of breast cancer from China to Italy.

Authors:  Alessia Levaggi; Francesca Poggio; Matteo Lambertini
Journal:  J Thorac Dis       Date:  2014-06       Impact factor: 2.895

Review 4.  The significance of cholesterol and its metabolite, 27-hydroxycholesterol in breast cancer.

Authors:  Erik R Nelson
Journal:  Mol Cell Endocrinol       Date:  2017-09-15       Impact factor: 4.102

5.  Choosing Breast Cancer Risk Models: Importance of Independent Validation.

Authors:  Mitchel H Gail
Journal:  J Natl Cancer Inst       Date:  2020-05-01       Impact factor: 13.506

6.  Variance computations for functional of absolute risk estimates.

Authors:  R M Pfeiffer; E Petracci
Journal:  Stat Probab Lett       Date:  2011-07-01       Impact factor: 0.870

7.  Long-Lasting Exceptional Radiological Complete Response after Treatment with Eribulin in a Patient with Triple-Negative Breast Cancer with Liver Involvement.

Authors:  Lorenzo Dottorini; Laura Catena; Italo Sarno; Giandomenico Di Menna; Annamaria Marte; Emilio Bajetta
Journal:  Oncology       Date:  2018-07-23       Impact factor: 2.935

8.  Common genetic polymorphisms modify the effect of smoking on absolute risk of bladder cancer.

Authors:  Montserrat Garcia-Closas; Nathaniel Rothman; Jonine D Figueroa; Ludmila Prokunina-Olsson; Summer S Han; Dalsu Baris; Eric J Jacobs; Nuria Malats; Immaculata De Vivo; Demetrius Albanes; Mark P Purdue; Sapna Sharma; Yi-Ping Fu; Manolis Kogevinas; Zhaoming Wang; Wei Tang; Adonina Tardón; Consol Serra; Alfredo Carrato; Reina García-Closas; Josep Lloreta; Alison Johnson; Molly Schwenn; Margaret R Karagas; Alan Schned; Gerald Andriole; Robert Grubb; Amanda Black; Susan M Gapstur; Michael Thun; William Ryan Diver; Stephanie J Weinstein; Jarmo Virtamo; David J Hunter; Neil Caporaso; Maria Teresa Landi; Amy Hutchinson; Laurie Burdett; Kevin B Jacobs; Meredith Yeager; Joseph F Fraumeni; Stephen J Chanock; Debra T Silverman; Nilanjan Chatterjee
Journal:  Cancer Res       Date:  2013-03-27       Impact factor: 12.701

9.  Using the Lorenz Curve to Characterize Risk Predictiveness and Etiologic Heterogeneity.

Authors:  Audrey Mauguen; Colin B Begg
Journal:  Epidemiology       Date:  2016-07       Impact factor: 4.822

10.  Occupational exposure and risk of breast cancer.

Authors:  Concettina Fenga
Journal:  Biomed Rep       Date:  2016-01-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.